Diana DeGette actually said...

Because the FDA can't possibly test every new drug that comes into the U.S., inspections of drug manufacturers abroad are a critical way to ...

The year after that hearing, the world was reminded why securing the global pharmaceutical supply chain is critical, when it was discovered ...

I look forward to working with my colleagues to advance bipartisan reform that will actually lower drug prices.

data challenges we identified in our 2008 report continue to make it difficult for FDA to accurately identify establishments subject to insp...